ULGX
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2015 Q3 | -0.02 | $3M | -$42,000 |
| 2014 Q2 | -0.02 | $3M | $20,000 |
| 2014 Q1 | -0.02 | $3M | -$173,000 |
| 2014 Q4 | -0.17 | $3M | -$98,000 |
| 2014 Q3 | -0.08 | $3M | -$451,000 |
| 2013 Q2 | -0.05 | $4M | -$284,000 |
| 2013 Q1 | -0.06 | $4M | -$739,000 |
| 2013 Q4 | -0.06 | $4M | -$1M |